Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 19, 2001

View Archived Issues

Study suggests topiramate may be useful in nicotine addiction

3M and GSK collaborate to formulate novel respiratory drugs

Interim results show OrCel's efficacy and speed in healing diabetic ulcers

NPS Pharmaceuticals continues progress during Q3 2001

New clinical studies support effectiveness of Eros Therapy in female sexual dysfunction

Blockade of mglu5 receptors reduces L-DOPA-induced dyskinesia

New HDL-elevating agent characterized by AtheroGenics at American Heart Association meeting

Antisense approach to preventing intimal hyperplasia post-PTCA examined in pig model

Survival of transplanted dopamine neurons significantly increased using CEP-1347

Fiscal Q2 at AnorMED marked by progress in clinical development programs

Catalytic antioxidant AEOL-10150 protects mice from ischemic brain damage

Peptide memory enhancer progresses through preclinical development

Orally active p38 MAP kinase effectively inhibits progression of collagen-induced arthritis

Phase II clinical results for 5G1.1 anticomplement antibody support further testing in RA

DPC-333, a selective, orally active TACE inhibitor with potential in inflammation

Uriach describes potent and selective COX-2 inhibitors

Novel 5-HT2C receptor antagonists and uses of these compounds patented by Fujisawa

Taisho discloses new series for renal and cerebrovascular disorders

Pyridyl-thiazolyl compounds for PDE4-mediated conditions

Orally available triterpenes for liver diseases

Merck receives patent coverage for new GnRH antagonists

FR-900482 analogues with antitumor activity under study in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...